JOURNEY MEDICAL CORP
NASDAQ: DERM (Journey Medical Corporation)
最近更新时间: 昨天, 1:20AM7.31
-0.05 (-0.68%)
| 前收盘价格 | 7.36 |
| 成交量 | 259,740 |
| 预期市盈率 (P/E Forward) | 10.30 |
| 价格/销量 (P/S) | 2.86 |
| 股市价格/股市净资产 (P/B) | 6.42 |
| 52周波幅 |
| 营业毛利率 | -14.76% |
| 营业利益率 (TTM) | -25.30% |
| 稀释每股收益 (EPS TTM) | -0.370 |
| 季度收入增长率 (YOY) | 0.80% |
| 总债务/股东权益 (D/E MRQ) | 116.83% |
| 流动比率 (MRQ) | 1.34 |
| 营业现金流 (OCF TTM) | -6.94 M |
| 杠杆自由现金流 (LFCF TTM) | -18.74 M |
| 资产报酬率 (ROA TTM) | -5.70% |
| 股东权益报酬率 (ROE TTM) | -48.14% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 看涨 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 看涨 | |
| 股票 | Journey Medical Corporation | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | 2.5 |
| 平均 | 0.79 |
|
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Core |
| 内部持股比例 | 30.89% |
| 机构持股比例 | 29.96% |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合